Showing results (171-180 of 399) with videos related to
Sort By:
Pageof 40
Clinical Immunology (Orlando, Fla.)|December 26, 2006
CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosisSamantha Jilek, Myriam Schluep, Andrea O Rossetti, et al.Blood|April 3, 2004
De novo T-cell generation in patients at different ages and stages of HIV-1 diseaseMassimo Nobile, Rafael Correa, José A M Borghans, et al.Scientific Reports|July 29, 2017
IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantationRoee Dvir, Vera Paloschi, Filippo Canducci, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 30, 2009
Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cellsDonatella Ciuffreda, Laura Codarri, Leo Buhler, et al.F1000Research|December 15, 2021
Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitisParaskevas Filippidis, Francois van Ouwenaller, Alberto Cerutti, et al.The Open Dentistry Journal|October 30, 2018
The IG- file use to Gauge the Apical Diameter in Endodontics: An In Vitro StudyMassimo Amato, Alfredo Iandolo, Giuseppe Pantaleo, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 6, 2013
The functional and structural neural basis of individual differences in loss aversionNicola Canessa, Chiara Crespi, Matteo Motterlini, et al.The Journal of Physical Chemistry. B|July 21, 2006
Relationship between structure and CO oxidation activity of ceria-supported gold catalystsAnna Maria Venezia, Giuseppe Pantaleo, Alessandro Longo, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease ModelsPhilipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, et al.Vaccines|January 18, 2020
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell VaccineCaroline Boudousquié, Valérie Boand, Emilie Lingre, et al.Pageof 40